George Church’s lab gets closer to creating human eggs in a dish, and a new startup plans to finish the job
By Ryan Cross,
Endpoints News
| 08. 19. 2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a step closer toward a technique that could one day allow people to grow eggs on demand.
The approach, known as in vitro gametogenesis, or IVG, would allow scientists to make eggs or sperm from adult stem cells. If scientists are successful, IVG could rewrite the rules of assisted reproduction by giving people with infertility and even same-sex couples the ability to have biological children through in vitro fertilization.
Church’s lab is one of a small number pursuing the controversial research. On Friday, its researchers published a new study in Science Advances showing they could coax adult stem cells into meiosis, the special form of cell division that germline stem cells use to create eggs and sperm, and thus a crucial step towards IVG.
The team only got the cells to go about two-thirds of the way through meiosis, after...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...